Wednesday, 20 November 2013

Sudan Pharmaceuticals and Healthcare Report Q1 2014

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Acquire Clients Globally!

Attention Advertisers: What's your CPA? Have Us Acquire Additional Clients for You Utilizing International, Localized PPC on AdWords, Bing, & Facebook Exchange!
From our sponsors
Sudan Pharmaceuticals and Healthcare Report Q1 2014
Nov 20th 2013, 00:00

Price: $ 1295  

BMI View: Disparity in the official and black market currency exchange rates, corruption and continual political tensions between Sudan and South Sudan will remain as downside risks to investments into the pharmaceutical sector. Consequently, we do not expect the market to be of particular interest to foreign pharmaceutical players. Headline Expenditure Projections ? Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.37bn (US$500mn) in 2013; +23.6% in local currency terms with a contraction of -7.1% in US dollar terms. Forecast broadly in line with Q413, growth contractions in US dollar terms due to currency fluctuations. ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment